These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 27333034)

  • 1. ADAM30 Downregulates APP-Linked Defects Through Cathepsin D Activation in Alzheimer's Disease.
    Letronne F; Laumet G; Ayral AM; Chapuis J; Demiautte F; Laga M; Vandenberghe ME; Malmanche N; Leroux F; Eysert F; Sottejeau Y; Chami L; Flaig A; Bauer C; Dourlen P; Lesaffre M; Delay C; Huot L; Dumont J; Werkmeister E; Lafont F; Mendes T; Hansmannel F; Dermaut B; Deprez B; Hérard AS; Dhenain M; Souedet N; Pasquier F; Tulasne D; Berr C; Hauw JJ; Lemoine Y; Amouyel P; Mann D; Déprez R; Checler F; Hot D; Delzescaux T; Gevaert K; Lambert JC
    EBioMedicine; 2016 Jul; 9():278-292. PubMed ID: 27333034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of peroxisome proliferator-activated receptor α stimulates ADAM10-mediated proteolysis of APP.
    Corbett GT; Gonzalez FJ; Pahan K
    Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8445-50. PubMed ID: 26080426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between ubiquilin-1 and BACE1 in human Alzheimer's disease and APdE9 transgenic mouse brain and cell-based models.
    Natunen T; Takalo M; Kemppainen S; Leskelä S; Marttinen M; Kurkinen KMA; Pursiheimo JP; Sarajärvi T; Viswanathan J; Gabbouj S; Solje E; Tahvanainen E; Pirttimäki T; Kurki M; Paananen J; Rauramaa T; Miettinen P; Mäkinen P; Leinonen V; Soininen H; Airenne K; Tanzi RE; Tanila H; Haapasalo A; Hiltunen M
    Neurobiol Dis; 2016 Jan; 85():187-205. PubMed ID: 26563932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased expression of cathepsin D in monocytes is related to the defective degradation of amyloid-β in Alzheimer's disease.
    Tian L; Zhang K; Tian ZY; Wang T; Shang DS; Li B; Liu DX; Fang WG; Wang ZY; Chen YH
    J Alzheimers Dis; 2014; 42(2):511-20. PubMed ID: 24898658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Folic Acid on Secretases Involved in Aβ Deposition in APP/PS1 Mice.
    Tian T; Bai D; Li W; Huang GW; Liu H
    Nutrients; 2016 Sep; 8(9):. PubMed ID: 27618097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Berberine ameliorates β-amyloid pathology, gliosis, and cognitive impairment in an Alzheimer's disease transgenic mouse model.
    Durairajan SS; Liu LF; Lu JH; Chen LL; Yuan Q; Chung SK; Huang L; Li XS; Huang JD; Li M
    Neurobiol Aging; 2012 Dec; 33(12):2903-19. PubMed ID: 22459600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arf6 controls beta-amyloid production by regulating macropinocytosis of the Amyloid Precursor Protein to lysosomes.
    Tang W; Tam JH; Seah C; Chiu J; Tyrer A; Cregan SP; Meakin SO; Pasternak SH
    Mol Brain; 2015 Jul; 8():41. PubMed ID: 26170135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cathepsin D: Analysis of its potential role as an amyloid beta degrading protease.
    Gallwitz L; Schmidt L; Marques ARA; Tholey A; Cassidy L; Ulku I; Multhaup G; Di Spiezio A; Saftig P
    Neurobiol Dis; 2022 Dec; 175():105919. PubMed ID: 36347423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine induces apoptosis in APPswe-expressing Neuro2A cells following Pepstatin-sensitive proteolysis of APP in acid compartments.
    Cagnin M; Ozzano M; Bellio N; Fiorentino I; Follo C; Isidoro C
    Brain Res; 2012 Aug; 1471():102-17. PubMed ID: 22771396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrolysin decreases amyloid-beta production by regulating amyloid protein precursor maturation in a transgenic model of Alzheimer's disease.
    Rockenstein E; Torrance M; Mante M; Adame A; Paulino A; Rose JB; Crews L; Moessler H; Masliah E
    J Neurosci Res; 2006 May; 83(7):1252-61. PubMed ID: 16511867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease.
    Collins JM; King AE; Woodhouse A; Kirkcaldie MT; Vickers JC
    Exp Neurol; 2015 May; 267():219-29. PubMed ID: 25747037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prolyl isomerase Pin1 regulates amyloid precursor protein processing and amyloid-beta production.
    Pastorino L; Sun A; Lu PJ; Zhou XZ; Balastik M; Finn G; Wulf G; Lim J; Li SH; Li X; Xia W; Nicholson LK; Lu KP
    Nature; 2006 Mar; 440(7083):528-34. PubMed ID: 16554819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Huntingtin associated protein 1 regulates trafficking of the amyloid precursor protein and modulates amyloid beta levels in neurons.
    Yang GZ; Yang M; Lim Y; Lu JJ; Wang TH; Qi JG; Zhong JH; Zhou XF
    J Neurochem; 2012 Sep; 122(5):1010-22. PubMed ID: 22731248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term treadmill exercise inhibits the progression of Alzheimer's disease-like neuropathology in the hippocampus of APP/PS1 transgenic mice.
    Liu HL; Zhao G; Zhang H; Shi LD
    Behav Brain Res; 2013 Nov; 256():261-72. PubMed ID: 23968591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p75NTR ectodomain is a physiological neuroprotective molecule against amyloid-beta toxicity in the brain of Alzheimer's disease.
    Yao XQ; Jiao SS; Saadipour K; Zeng F; Wang QH; Zhu C; Shen LL; Zeng GH; Liang CR; Wang J; Liu YH; Hou HY; Xu X; Su YP; Fan XT; Xiao HL; Lue LF; Zeng YQ; Giunta B; Zhong JH; Walker DG; Zhou HD; Tan J; Zhou XF; Wang YJ
    Mol Psychiatry; 2015 Nov; 20(11):1301-10. PubMed ID: 25917367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folic acid deficiency enhances abeta accumulation in APP/PS1 mice brain and decreases amyloid-associated miRNAs expression.
    Liu H; Tian T; Qin S; Li W; Zhang X; Wang X; Gao Y; Huang G
    J Nutr Biochem; 2015 Dec; 26(12):1502-8. PubMed ID: 26345540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokine-producing microglia have an altered beta-amyloid load in aged APP/PS1 Tg mice.
    Babcock AA; Ilkjær L; Clausen BH; Villadsen B; Dissing-Olesen L; Bendixen AT; Lyck L; Lambertsen KL; Finsen B
    Brain Behav Immun; 2015 Aug; 48():86-101. PubMed ID: 25774009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Murine Aβ over-production produces diffuse and compact Alzheimer-type amyloid deposits.
    Xu G; Ran Y; Fromholt SE; Fu C; Yachnis AT; Golde TE; Borchelt DR
    Acta Neuropathol Commun; 2015 Nov; 3():72. PubMed ID: 26566997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. APP overexpression in the absence of NPC1 exacerbates metabolism of amyloidogenic proteins of Alzheimer's disease.
    Maulik M; Peake K; Chung J; Wang Y; Vance JE; Kar S
    Hum Mol Genet; 2015 Dec; 24(24):7132-50. PubMed ID: 26433932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activated protein C inhibits amyloid β production via promoting expression of ADAM-10.
    Li B; Yu D; Xu Z
    Brain Res; 2014 Jan; 1545():35-44. PubMed ID: 24333930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.